Welly Bravery Triple Antibiotic With Pain Relief
NDC Package 72663-161-60

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Welly Bravery Triple Antibiotic With Pain Relief is adults and children 2 years of age and olderclean the affected areaapply a small amount (equal to surface area of tip of finger) on the area 1 to 3 times daily.may be covered with a sterile bandageChildren under 2 years of age; ask a doctor. Marketed by Welly Health Pbc, this product is identified by NDC 72663-161 and is authorized under FDA application part333B.

Identification & Billing

NDC Package Code
72663-161-60
Package Description
1 TUBE in 1 CASE / 14 g in 1 TUBE
Product Code
72663-161
11-Digit Billing Format
72663016160
RxNorm Crosswalk
  • RxCUI: 1359350 - bacitracin 500 UNT / neomycin 3.5 MG / polymyxin B 10,000 UNT / pramoxine HCl 10 MG in GM Topical Ointment
  • RxCUI: 1359350 - bacitracin 0.5 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 10 UNT/MG / pramoxine hydrochloride 0.01 MG/MG Topical Ointment
  • RxCUI: 1359350 - bacitracin 500 UNT / neomycin 3.5 MG / polymyxin B 10,000 UNT / pramoxine HCl 10 MG per GM Topical Ointment

Clinical Specifications

Proprietary Name
Welly Bravery Triple Antibiotic With Pain Relief
Dosage Form
-
Usage Information
Adults and children 2 years of age and olderclean the affected areaapply a small amount (equal to surface area of tip of finger) on the area 1 to 3 times daily.may be covered with a sterile bandageChildren under 2 years of age; ask a doctor

Regulatory & Marketing

Labeler Name
Welly Health Pbc
FDA Application #
part333B
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
01-31-2019
Listing Expiration
12-31-2025
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 72663-161-60 identifies a specific commercial package of 1 tube in 1 case / 14 g in 1 tube of Welly Bravery Triple Antibiotic With Pain Relief, labeled by Welly Health Pbc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Welly Health Pbc on January 31, 2019. The current certification is valid through December 31, 2025.

How is this Welly Health Pbc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 72663016160. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
72663-161-60
11-Digit CMS (5-4-2)
72663-0161-60

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.